# TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)

> **NCT04936243** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 30 (actual)

## Conditions studied

- Breast Cancer
- Prostate Cancer
- Patient Engagement
- Patient Preference
- Patient Satisfaction

## Interventions

- **BEHAVIORAL:** FOLLOW UP VISIT-TELEMEDICINE
- **BEHAVIORAL:** FOLLOW UP VISIT-FACE TO FACE

## Key facts

- **NCT ID:** NCT04936243
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04936243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04936243, "TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04936243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*